Literature DB >> 6191429

Specificity of the enzyme-linked immunosorbent assay (ELISA) for antibodies in the sera of specific pathogen-free lambs vaccinated with Pasteurella haemolytica antigens.

W Donachie, C Burrells, A M Dawson.   

Abstract

Pooled serum from specific pathogen-free (SPF) lambs vaccinated with sodium salicylate extracted (SSE) antigens of Pasteurella haemolytica serotype A1 was shown to contain antibody to other A serotype SSE antigens when tested by the enzyme-linked immunosorbent assay (ELISA). Specific antibody to serotype A1 SSE antigens was demonstrated by absorption of the serum pool with heterologous serotype SSE antigens. The type-specific antigens of serotypes A1 and A9 were prepared by phenol--water extraction (PWE) of their respective SSE antigens. The PWE antigens were examined in a sandwich ELISA where rabbit IgG anti-P. haemolytica A1 cells or A9 cells was used as a coating layer to bind PWE antigens. The specificity of these antigens was demonstrated by marked reduction of reactivity between serum from SPF lambs vaccinated with SSE of serotypes A1 or A9.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191429     DOI: 10.1016/0378-1135(83)90066-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE.

Authors:  Sahlu Ayalew; Anthony W Confer; Emily R Blackwood
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Cloning of a serotype-specific antigen from Pasteurella haemolytica A1.

Authors:  C Gonzalez-Rayos; R Y Lo; P E Shewen; T J Beveridge
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay for detection of serum antibodies to Pasteurella haemolytica cytotoxin (leukotoxin) in cattle.

Authors:  D A Mosier; A W Confer; S M Hall; M J Gentry; R J Panciera
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

4.  Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.

Authors:  Tor-Arne Hegvik; Kai Waløen; Sunil K Pandey; Stephen V Faraone; Jan Haavik; Tetyana Zayats
Journal:  Mol Psychiatry       Date:  2019-10-18       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.